Clinical Trial Update: Trastuzumab Deruxtecan With Nivolumab in Advanced Breast and Urothelial Cancer [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the combination of trastuzumab deruxtecan with nivolumab in advanced breast cancer and urothelial carcinoma has completed, with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Urothelial Carcinoma

Drugs mentioned

• Enhertu (trastuzumab deruxtecan)
• nivolumab (nivolumab)

Snippet

Sponsor: Daiichi Sankyo | Conditions: Breast Cancer, Urothelial Carcinoma | Phase 1 | Status: COMPLETED | Results posted: 2025-01-27